The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations
Open accessAbstract
BACKGROUND: Point-of-care testing of C-reactive protein (CRP) may be a way to reduce unnecessary use of antibiotics without harming patients who have acute exacerbations of chronic obstructive pulmonary disease (COPD). METHODS: We performed a multicenter, open-label, randomized, controlled trial involving patients with a diagnosis of COPD in their primary care clinical record who consulted a clinician at 1 of 86 general medical practices in England and Wales for an acute exacerbation of COPD. The patients were assigned to receive usual care guided by CRP point-of-care testing (CRP-guided group) or usual care alone (usual-care group). The primary outcomes were patient-reported use of antibiotics for acute exacerbations of COPD within 4 weeks after randomization (to show superiority) and COPD-related health status at 2 weeks after randomization, as measured by the Clinical COPD Questionnaire, a 10-item scale with scores ranging from 0 (very good COPD health status) to 6 (extremely poor COPD health status) (to show noninferiority). RESULTS: A total of 653 patients underwent randomization. Fewer patients in the CRP-guided group reported antibiotic use than in the usual-care group (57.0% vs. 77.4%; adjusted odds ratio, 0.31; 95% confidence interval [CI], 0.20 to 0.47). The adjusted mean difference in the total score on the Clinical COPD Questionnaire at 2 weeks was -0.19 points (two-sided 90% CI, -0.33 to -0.05) in favor of the CRP-guided group. The antibiotic prescribing decisions made by clinicians at the initial consultation were ascertained for all but 1 patient, and antibiotic prescriptions issued over the first 4 weeks of follow-up were ascertained for 96.9% of the patients. A lower percentage of patients in the CRP-guided group than in the usual-care group received an antibiotic prescription at the initial consultation (47.7% vs. 69.7%, for a difference of 22.0 percentage points; adjusted odds ratio, 0.31; 95% CI, 0.21 to 0.45) and during the first 4 weeks of follow-up (59.1% vs. 79.7%, for a difference of 20.6 percentage points; adjusted odds ratio, 0.30; 95% CI, 0.20 to 0.46). Two patients in the usual-care group died within 4 weeks after randomization from causes considered by the investigators to be unrelated to trial participation. CONCLUSIONS: CRP-guided prescribing of antibiotics for exacerbations of COPD in primary care clinics resulted in a lower percentage of patients who reported antibiotic use and who received antibiotic prescriptions from clinicians, with no evidence of harm. (Funded by the National Institute for Health Research Health Technology Assessment Program; PACE Current Controlled Trials number, ISRCTN24346473.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
Identification of Causal Effects Using Instrumental Variables
Angrist, J. D., Imbens, G. W., & Rubin, D. B. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476902 · Cited by 4,230
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., Linder, J. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.4151 · Cited by 1,740
A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., Tunis, S., Bergel, E., Harvey, I., Magid, D. J., et al. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.12.011 · Cited by 1,389
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072
Development, validity and responsiveness of the Clinical COPD Questionnaire.
van der Molen, T., Willemse, B. W. M., Schokker, S., ten Hacken, N. H. T., Postma, D. S., & Juniper, E. F. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-13 · Cited by 733
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1553oc · Cited by 612
Hicks, L. A., Bartoces, M. G., Roberts, R. M., Suda, K. J., Hunkler, R. J., Taylor, T. H., & Schrag, S. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ076 · Cited by 559
Cals, J. W. L., Butler, C. C., Hopstaken, R. M., Hood, K., & Dinant, G.-J. (2009) · BMJ · doi:10.1136/bmj.b1374 · Cited by 498
Self-citationUse of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Vollenweider, D. J., Jarrett, H., Steurer-Stey, C. A., Garcia-Aymerich, J., & Puhan, M. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010257 · Cited by 425
Assessing the value of diagnostic tests: a framework for designing and evaluating trials
Ferrante di Ruffano, L., Hyde, C. J., McCaffery, K. J., Bossuyt, P. M. M., & Deeks, J. J. (2012) · BMJ · doi:10.1136/bmj.e686 · Cited by 334
Measurement Properties and Interpretability of the Chronic Respiratory Disease Questionnaire (CRQ)
Schünemann, H. J., Puhan, M., Goldstein, R., Jaeschke, R., & Guyatt, G. H. (2005) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200050651 · Cited by 287
Aabenhus, R., Jensen, J.-U. S., Jørgensen, K. J., Hróbjartsson, A., & Bjerrum, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010130.pub2 · Cited by 228
Little, P., Stuart, B., Moore, M., Coenen, S., Butler, C. C., Godycki-Cwirko, M., Mierzecki, A., Chlabicz, S., Torres, A., Almirall, J., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70300-6 · Cited by 221
Self-citationKocks, J., Tuinenga, M., Uil, S., van den Berg, J., Ståhl, E., & van der Molen, T. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-62 · Cited by 219
Tonkin-Crine, S. K., Tan, P. S., van Hecke, O., Wang, K., Roberts, N. W., McCullough, A., Hansen, M. P., Butler, C. C., & Del Mar, C. B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012252.pub2 · Cited by 213
Self-citationFrom biomarkers to medical tests: the changing landscape of test evaluation
Horvath, A. R., Lord, S. J., StJohn, A., Sandberg, S., Cobbaert, C. M., Lorenz, S., Monaghan, P. J., Verhagen-Kamerbeek, W. D. J., Ebert, C., & Bossuyt, P. M. M. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.09.018 · Cited by 203
Wheaton, A. G., Cunningham, T. J., Ford, E. S., & Croft, J. B. (2015) · PubMed Central · Cited by 192
Lindenauer, P. K., Pekow, P., Gao, S., Crawford, A. S., Gutierrez, B., & Benjamin, E. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00006 · Cited by 190
Llor, C., Moragas, A., Hernandez, S. F., Bayona, C., & Miravitlles, M. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-0996oc · Cited by 151
Self-citationSchool Start Times for Middle School and High School Students — United States, 2011–12 School Year
Wheaton, A. G., Ferro, G., Croft, J. B., & text, A. A. A. E. O. (2015) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6430a1 · Cited by 142
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
Mathioudakis, A. G., Chatzimavridou-Grigoriadou, V., Corlăteanu, A., & Vestbo, J. (2017) · European Respiratory Review · doi:10.1183/16000617.0073-2016 · Cited by 126
Cals, J., Bock, L., Beckers, P.-J., Francis, N. A., Hopstaken, R., Hood, K., de Bont, E. G. P. M., Butler, C., & Dinant, G. (2013) · The Annals of Family Medicine · doi:10.1370/afm.1477 · Cited by 120
Self-citationMiravitlles, M., Moragas, A., Hernandez, S. F., Bayona, C., & Llor, C. (2013) · CHEST Journal · doi:10.1378/chest.13-0518 · Cited by 91
Self-citationSchroeck, J. L., Ruh, C. A., Sellick, J. A., Ott, M. C., Mattappallil, A., & Mergenhagen, K. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00652-15 · Cited by 88
A Comparison of the Original Chronic Respiratory Questionnaire With a Standardized Version
Schünemann, H. J., Griffith, L. E., Jaeschke, R., Goldstein, R. S., Stubbing, D. G., Austin, P., & Guyatt, G. H. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1421 · Cited by 87
Antibiotic Treatment of Acute Respiratory Infections in Acute Care Settings
Gonzales, R., Camargo, C. A., MacKenzie, T. D., Kersey, A. S., Maselli, J. H., Levin, S. K., McCulloch, C. E., & Metlay, J. P. (2006) · Academic Emergency Medicine · doi:10.1197/j.aem.2005.10.016 · Cited by 74
Nacul, L., Soljak, M., Samarasundera, E., Hopkinson, N. S., Lacerda, E., Indulkar, T., Flowers, J., Walford, H., & Majeed, A. (2010) · Journal of Public Health · doi:10.1093/pubmed/fdq031 · Cited by 71
Cosby, J., Francis, N. A., & Butler, C. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70263-3 · Cited by 70
Self-citationCommon evidence gaps in point-of-care diagnostic test evaluation: a review of horizon scan reports
Verbakel, J. Y. J., Turner, P. J., Thompson, M. J., Plüddemann, A., Price, C. P., Shinkins, B., & den Bruel, A. V. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015760 · Cited by 66
van Velzen, P., ter Riet, G., Bresser, P., Baars, J. J., van den Berg, B. T. J., van den Berg, J. W., Brinkman, P., Dagelet, J. W. F., Daniels, J. M. A., Groeneveld-Tjiong, D. R. G. L., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30165-0 · Cited by 51
Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice
Llor, C., Bjerrum, L., Munck, A., Hansen, M. P., Córdoba, G., Strandberg, E. L., Ovhed, I., Radzevičienė, R., Cots, J. M., Reutskiy, A., et al. (2013) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465812472387 · Cited by 39
Self-citationMinnaard, M. C., van de Pol, A. C., de Groot, J. A. H., de Wit, N. J., Hopstaken, R., van Delft, S., Goossens, H., Ieven, M. M., Lammens, C., Little, P. S., et al. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1006136 · Cited by 34
Self-citationUse of co-primary outcomes for trials of antimicrobial stewardship interventions
Gillespie, D., Francis, N. A., Carrol, E. D., Thomas‐Jones, E., Butler, C., & Hood, K. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30289-5 · Cited by 19
Self-citationHarries, T., Seed, P. T., Jones, S., Schofield, P., & White, P. T. (2014) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2014.6 · Cited by 18
Self-citationBates, J., Francis, N. A., White, P. T., Gillespie, D., Thomas‐Jones, E., Breen, R., Kirby, N., Hood, K., Gal, M., Phillips, R., et al. (2017) · Trials · doi:10.1186/s13063-017-2144-8 · Cited by 18
Self-citation
Cited by
Celli, B. R., Fabbri, L. M., Aaron, S. D., Agusti, A., Brook, R., Criner, G. J., Franssen, F. M. E., Humbert, M., Hurst, J. R., O’Donnell, D., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202108-1819pp · Cited by 371
MacLeod, M., Papi, A., Contoli, M., Beghé, B., Celli, B. R., Wedzicha, J. A., & Fabbri, L. M. (2021) · Respirology · doi:10.1111/resp.14041 · Cited by 359
Ren, F., Huang, J., Dai, T., & Gan, F. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-525 · Cited by 8
Metadata
- Authors
- Butler, C. C., Gillespie, D., White, P., Bates, J., Lowe, R., Thomas-Jones, E., Wootton, M., Hood, K., Phillips, R., Melbye, H., Llor, C., Cals, J. W. L., Naik, G., Kirby, N., Gal, M., Riga, E., & Francis, N. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-07-11
- Volume
- 381
- Issue
- 2
- Pages
- 111-120
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2957912127
- Cited by
- 277
- References
- 40
- FWCI
- 26.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.